Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 6/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2578206 | 0.78 | ALDH1A1 (0.52) | CYP2A6ALDH1A1NPSR1MAPTMEN1 | |
| SCHEMBL1738285 | 0.76 | ACHE (0.44) | CYP2A6ALDH1A1NPSR1MAPTMEN1 | |
| SCHEMBL29254129 | 0.74 | POLB (0.38) | ALDH1A1MAPTMEN1KMT2ALMNA | |
| SCHEMBL29254132 | 0.74 | CYP2A6 (0.42) | CYP2A6ALDH1A1NPSR1MAPTLMNA | |
| SCHEMBL5835289 | 0.74 | ACHE (0.42) | CYP2A6ALDH1A1NPSR1MAPTMEN1 | |
| SCHEMBL14767314 | 0.74 | ACHE (0.42) | CYP2A6ALDH1A1NPSR1MAPTMEN1 | |
| P-Xylene SCHEMBL5241939 | 0.74 | CYP2A6 (0.58) | CYP2A6ALDH1A1NPSR1MAPTMEN1 | |
| Formic Acid SCHEMBL10703547 | 0.73 | CYP2A6 (0.41) | CYP2A6ALDH1A1NPSR1MAPTMEN1 | |
| SCHEMBL10736506 | 0.72 | MEN1 (0.47) | CYP2A6ALDH1A1NPSR1MAPTMEN1 | |
| SCHEMBL10736502 | 0.72 | MEN1 (0.47) | CYP2A6ALDH1A1NPSR1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100237770-A1 | GOLD COMPLEX AND PROCESS FOR PREPARING THE SAME, AND ORGANIC ULTRAVIOLET ELECTROLUMINESCENT DEVICE USING SAID GOLD COMPLEX | UBE INDUSTRIES, LTD. (JP) | 2010-09-23 | — | — | US | claimed |
| EP-2088151-A1 | GOLD COMPLEX, METHOD FOR PRODUCTION OF THE GOLD COMPLEX, AND ORGANIC ULTRAVIOLET ELECTROLUMINESCENT ELEMENT USING THE GOLD COMPLEX | Ube Industries, Ltd. (JP) | 2009-08-12 | — | — | EP | claimed |
| CN-118005546-A | Method for synthesizing thiocarboxylate based on unsaturated hydrocarbon | 安徽农业大学 | 2024-05-10 | — | — | CN | disclosed |
| US-20100237770-A1 | GOLD COMPLEX AND PROCESS FOR PREPARING THE SAME, AND ORGANIC ULTRAVIOLET ELECTROLUMINESCENT DEVICE USING SAID GOLD COMPLEX | UBE INDUSTRIES, LTD. (JP) | 2010-09-23 | — | — | US | disclosed |
| EP-2088151-A1 | GOLD COMPLEX, METHOD FOR PRODUCTION OF THE GOLD COMPLEX, AND ORGANIC ULTRAVIOLET ELECTROLUMINESCENT ELEMENT USING THE GOLD COMPLEX | Ube Industries, Ltd. (JP) | 2009-08-12 | — | — | EP | disclosed |
| CN-1080732-C | Process for producing epoxy compound | DOW CHEMICAL CO (US) | 2002-03-13 | — | — | CN | disclosed |
| CN-1066464-C | Process for preparing allyl ether, thioether and amine compounds | DOW CHEMICAL CO (US) | 2001-05-30 | — | — | CN | disclosed |
| EP-0799262-B1 | PROCESS FOR PREPARATION OF EPOXY COMPOUNDS | DOW CHEMICAL CO (US) | 2001-01-03 | — | — | EP | disclosed |
| US-5908943-A | Process for preparation of epoxy compounds essentially free of organic halides | THE DOW CHEMICAL COMPANY (US) | 1999-06-01 | — | — | US | disclosed |
| EP-0799261-B1 | PROCESS FOR PREPARATION OF ALLYL ETHER, THIOETHER AND AMINE COMPOUNDS | DOW CHEMICAL CO (US) | 1999-05-26 | — | — | EP | disclosed |
| CN-1171124-A | Process for producing epoxy compound | DOW CHEMICAL CO (US) | 1998-01-21 | — | — | CN | disclosed |
| CN-1171125-A | Process for preparing allyl ether, thioether and amine compounds | DOW CHEMICAL CO (US) | 1998-01-21 | — | — | CN | disclosed |
| US-5578740-A | Process for preparation of epoxy compounds essentially free of organic halides | THE DOW CHEMICAL COMPANY (US) | 1996-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100237770-A1 | GOLD COMPLEX AND PROCESS FOR PREPARING THE SAME, AND ORGANIC ULTRAVIOLET ELECTROLUMINESCENT DEVICE USING SAID GOLD COMPLEX | APOL1, UFL1, ACSL3 | CYP2A6 2437/4885ALDH1A1 435/4885NPSR1 2963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.